CtrlK
10X Genomics
TXG53
$9.88arrow_drop_down9.12%-$0.99
TXG53
$9.88
arrow_drop_down9.12%Performance History
There's no data available for performance history chart
| Key Stats | |
|---|---|
| Open | $10.75 |
| Prev. Close | $10.85 |
| EPS | -1.52 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $1.30B |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 9.87 | 11.12 |
| 52 Week Range | 9.31 | 57.90 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
There's no data available for Analyst Forecast
Period: -
• Predicted: -Analyst Ratings
There's no data available for Analyst Ratings
Last updated: -
• Total: -About 10X Genomics (TXG)
- Sector
- Healthcare
- Industry
- Health Information Services
- CEO
- Dr. Serge Saxonov Ph.D.
- Headquarters
- Pleasanton
- Employees
- 1243
- Exchange
- NASDAQ
Keep an eye on 10X Genomics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is 10X Genomics 's (TXG) price per share?
The current price per share for 10X Genomics (TXG) is $9.88. The stock has seen a price change of -$0.99 recently, indicating a -9.12% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for 10X Genomics (TXG)?
For 10X Genomics (TXG), the 52-week high is $57.9, which is 486.03% from the current price. The 52-week low is $9.31, the current price is 6.11% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is 10X Genomics (TXG) a growth stock?
10X Genomics (TXG) has shown an average price growth of -1.65% over the past three years. It has received a score of 9 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying 10X Genomics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is 10X Genomics (TXG) stock price performance year to date (YTD)?
As of the latest data, 10X Genomics (TXG) has a year-to-date price change of -31.2%. Over the past month, the stock has experienced a price change of -17.67%. Over the last three months, the change has been -33.91%. Over the past six months, the figure is -56.19%. Looking at a longer horizon, the five-year price change stands at -83.42%.
help
Is 10X Genomics (TXG) a profitable company?
10X Genomics (TXG) has a net income of -$182.63M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 67.86% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -30.2% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $610.78M, although specific revenue growth data is currently not available. The gross profit is $414.48M. Operating income is noted at -$194.56M. Furthermore, the EBITDA is -$156.58M.
help
What is the market capitalization of 10X Genomics (TXG)?
10X Genomics (TXG) has a market capitalization of $1.3B. The average daily trading volume is 10.19, indicating the stock's liquidity and investor engagement.